ImmuCell Corporation (ICCC) vs PMV Pharmaceuticals, Inc. (PMVP)
A side-by-side comparison of ImmuCell Corporation and PMV Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ICCC
ImmuCell Corporation
$9.88HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
PMVP
PMV Pharmaceuticals, Inc.
$1.68HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
Total return — ICCC vs PMVP
growth of $100 · dividends reinvested · last 6yICCC +82.6% (+10.6%/yr)PMVP -95.3% (-39.8%/yr)ICCC compounded faster over this window
Log scale — wide-divergence pair
ICCC PMVP
ICCC vs PMVP: by the numbers
- •PMVP is the larger company ($90M vs $89M market cap).
- •ICCC is profitable (2.57% net margin) while PMVP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ICCC | PMVP |
|---|---|---|
| P/E ratio | 116.73 | N/A |
| P/S ratio | 2.91 | N/A |
| P/B ratio | 2.85 | 1.25 |
| EV / EBITDA | 14.87 | N/A |
| FCF yield | 4.72% | N/A |
Profitability
| Metric | ICCC | PMVP |
|---|---|---|
| Gross margin | 40.32% | 0.00% |
| Operating margin | 12.60% | 0.00% |
| Net margin | 2.57% | 0.00% |
| ROE | 2.51% | -105.20% |
| ROIC | 8.16% | -111.42% |
Growth (annualized)
| Metric | ICCC | PMVP |
|---|---|---|
| Revenue CAGR (5Y) | 13.74% | N/A |
| Total return CAGR (5Y) | 0.65% | -43.17% |
Frequently asked
- Is ICCC or PMVP more profitable?
- ICCC runs the higher net margin — ICCC at 2.57% versus PMVP at 0.00%.
- How have ICCC and PMVP total returns compared?
- Over the past 5 years, ICCC delivered 0.65% and PMVP delivered -43.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
ImmuCell P/E ratioImmuCell ROEPMV Pharmaceuticals ROEImmuCell operating marginPMV Pharmaceuticals operating marginImmuCell revenue growthPMV Pharmaceuticals revenue growthImmuCell free cash flowPMV Pharmaceuticals free cash flow
ImmuCell & PMV Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.